Author:
Philippou Anastassios,Maridaki Maria,Karatzas Theodore,Koutsilieris Michael
Publisher
Springer International Publishing
Reference100 articles.
1. Laviola L, Natalicchio A, Giorgino F. The igf-i signaling pathway. Curr Pharm Des. 2007;13:663–9.
2. Le Roith D. Seminars in medicine of the beth Israel deaconess medical center. Insulin-like growth factors. N Engl J Med. 1997;336:633–40.
3. Ren J, Samson WK, Sowers JR. Insulin-like growth factor i as a cardiac hormone: physiological and pathophysiological implications in heart disease. J Mol Cell Cardiol. 1999;31:2049–61.
4. Philippou A, Maridaki M, Halapas A, Koutsilieris M. The role of the insulin-like growth factor 1 (igf-1) in skeletal muscle physiology. In Vivo. 2007;21:45–54.
5. Barton ER, Park S, James JK, Makarewich CA, Philippou A, Eletto D, et al. Deletion of muscle grp94 impairs both muscle and body growth by inhibiting local igf production. FASEB J. 2012;26:3691–702.